Placebo HandiHaler®

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 2

Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02238106

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2005-09-30Updated: 2014-09-12

Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02242253

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2003-09-30Updated: 2014-09-17